Elite Pharmaceuticals ELTP
OTC ELTP
$0.25 +0.00 (+0.00%)
At close: Oct 15, 2026 · 4:00 PM EDT

Elite Pharmaceuticals (ELTP) Non-Current Assets (2011 - 2026)

Updated

Elite Pharmaceuticals' Non-Current Assets was $25.18 million in fiscal Q1 2027 (quarter ended Jun 30, 2026), down 24.8% from $33.48 million a year earlier and down 3.8% from the prior quarter.

Analysis

Elite Pharmaceuticals (ELTP) Non-Current Assets (2011 - 2026) Analysis & Trends

At the end of FY2026 (ended Mar 31, 2026), Non-Current Assets at Elite Pharmaceuticals came in at $26.18 million, down 32.3% from FY2025.

  • Non-Current Assets shows a five-year compound annual growth rate of 13.3% (FY2021 to FY2026).
  • In earlier fiscal years, Non-Current Assets was $38.65 million in FY2025 (-11.4%), $43.64 million in FY2024 (+125.1%), $19.39 million in FY2023 (+19.0%) and $16.29 million in FY2022 (+16.4%).
  • The fiscal Q1 2027 figure marks the lowest quarterly Non-Current Assets since fiscal Q1 2024.
  • Compared with a year earlier, Non-Current Assets has declined for six straight quarters, with an average decline of 14.7% over the last eight quarters.
  • The best year-over-year quarter for Non-Current Assets over five years was fiscal Q1 2025 (growth of 134.5%); the worst was fiscal Q4 2026 (a decline of 32.3%).
  • Per Business Quant data, ELTP's Non-Current Assets in the three fiscal quarters before Q1 2027 was $26.18 million (Q4 2026), $29.62 million (Q3 2026) and $31.45 million (Q2 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Eli Lilly 1,128.06 Bn 1,096.64 Bn 19.71 Bn 77.61 Bn
2 Johnson & Johnson 615.47 Bn 534.00 Bn 17.26 Bn 141.29 Bn
3 AbbVie 504.80 Bn 477.91 Bn 12.70 Bn 101.45 Bn
4 Merck 368.45 Bn 322.83 Bn 12.21 Bn 125.00 Mn
5 Novartis Ag 298.44 Bn 262.43 Bn 11.24 Bn 94.68 Bn
6 Astrazeneca 261.92 Bn 235.60 Bn 12.86 Bn 87.87 Bn
7 Amgen 236.10 Bn 191.50 Bn 7.24 Bn 60.68 Bn
8 Gilead Sciences 190.71 Bn 164.91 Bn 6.22 Bn 35.42 Bn
9 Pfizer 170.16 Bn 116.81 Bn 10.94 Bn 159.77 Bn
10 Elite Pharmaceuticals 257.03 Mn 138.70 Mn 13.51 Mn 25.18 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 25.18 Mn
Mar 31, 2026 26.18 Mn
Dec 31, 2025 29.62 Mn
Sep 30, 2025 31.45 Mn
Jun 30, 2025 33.48 Mn
Mar 31, 2025 38.65 Mn
Dec 31, 2024 42.71 Mn
Sep 30, 2024 42.90 Mn
Jun 30, 2024 44.69 Mn
Mar 31, 2024 43.64 Mn
Dec 31, 2023 37.54 Mn
Sep 30, 2023 35.99 Mn
Jun 30, 2023 19.05 Mn
Mar 31, 2023 19.39 Mn
Dec 31, 2022 19.55 Mn
Sep 30, 2022 19.87 Mn
Mar 31, 2022 16.29 Mn
Dec 31, 2021 14.47 Mn
Sep 30, 2021 14.74 Mn
Jun 30, 2021 14.68 Mn
API Access

Elite Pharmaceuticals Non-Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-assets&ticker=ELTP&period=max&api_key=YOUR_API_KEY